Treatment of systemic lupus erythematosus with mycophenolate mofetil

Dwomoa Adu, J Cross, DR Jayne

Research output: Contribution to journalReview article

57 Citations (Scopus)


Mycophenolate mofetil is an immunosuppressive drug that is of established efficacy in renal transplantation. It inhibits the de novo pathway of purine synthesis and therefore lymphocyte proliferation. Mycophenylate mofetil has been shown to ameliorate the severity of renal injury in murine models of lupus nephritis. Recent studies suggest that it may also be effective in the treatment of patients with lupus nephritis when used in conjunction with steroids. These observations need to be confirmed in adequately sized randomised-controlled studies.
Original languageEnglish
Pages (from-to)203-208
Number of pages6
Issue number3
Publication statusPublished - 1 Mar 2001


Dive into the research topics of 'Treatment of systemic lupus erythematosus with mycophenolate mofetil'. Together they form a unique fingerprint.

Cite this